Group 1 - Diamond Hill Capital's "Small Cap Strategy" reported a favorable performance in Q4 2025, with the Russell 2000 Index returning 2.19% and a yearly gain of 12.81% [1] - The health care sector was the best performer in the Russell 2000 Index, achieving an 18.6% return [1] - The Strategy outperformed the Russell 2000 Index in Q4 2025, returning 4.88% net of fees [1] Group 2 - Transcat, Inc. (NASDAQ:TRNS) was highlighted in the investor letter, providing calibration and laboratory instrument services to regulated industries [2][3] - Transcat, Inc. experienced a one-month return of 11.70% but saw a 52-week decline of 9.21%, with a market capitalization of $659.226 million as of February 4, 2026 [2] - The company reported a 21% increase in consolidated revenue to $83 million in the fiscal second quarter of 2026 [5] Group 3 - Transcat, Inc. has strong recurring revenue streams due to regulatory demands and a successful acquisition track record, alongside a solid balance sheet [3] - The company was held by 18 hedge fund portfolios at the end of Q3 2025, an increase from 12 in the previous quarter [5]